Notice Information
Notice Title
Multiple Sclerosis Management Service for Children - Contract Modification
Notice Description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.
Lot Information
Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,
The service is currently delivered by 6 providers across the 3 Lots. The service will continue for the duration of this modification.
Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of EnglandThis exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Lot 3 - London and the South: comprising the South East; the South West; LondonThis exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.
Procurement Information
Following the PIN notice and market engagement exercise, it was apparent that competition was absent and direct awards have been placed with all capable providers for each of the Lots. The PIN and market engagement documentation clearly stated that commissioners would consider placing direct awards where competition is deemed to be absent following a review of the market engagement responses.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-038737
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/045613-2026
- Current Stage
- Award
- All Stages
- Planning, Award
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
-
- CPV Codes
85000000 - Health and social work services
85100000 - Health services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £21,992,955 £10M-£100M
Notice Dates
- Publication Date
- 19 May 20261 months ago
- Submission Deadline
- Not specified
- Future Notice Date
- 12 Jan 2023Expired
- Award Date
- 10 Mar 20233 years ago
- Contract Period
- 31 Mar 2026 - 30 Nov 2026 6-12 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Additional Buyers
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 6LH
- Post Town
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI45 Lambeth
- Delivery Location
- TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)
-
- Local Authority
- Lambeth
- Electoral Ward
- Waterloo & South Bank
- Westminster Constituency
- Vauxhall and Camberwell Green
Supplier Information
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-038737-2026-05-19T08:48:32+01:00",
"date": "2026-05-19T08:48:32+01:00",
"ocid": "ocds-h6vhtk-038737",
"description": "This is a Provider Selection Regime(PSR) contract modification notice, under the Health Care Services(Provider Selection Regime)Regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally modified.<br/>This contract modification was approved by the National Commissioning Group on 20th January 2026.",
"initiationType": "tender",
"tender": {
"id": "C442430",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"mainProcurementCategory": "services",
"description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.",
"lots": [
{
"id": "1",
"title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
"description": "The service is currently delivered by 6 providers across the 3 Lots. The service will continue for the duration of this modification.",
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Technical",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": false,
"contractPeriod": {
"durationInDays": 1080
}
},
{
"id": "2",
"title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
"description": "This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.",
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Technical",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": false
},
{
"id": "3",
"title": "Lot 3 - London and the South: comprising the South East; the South West; London",
"description": "This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.",
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Technical",
"type": "cost",
"description": "100"
}
]
},
"hasOptions": false
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKE"
},
{
"region": "UKD"
},
{
"region": "UKC"
},
{
"region": "UKE"
},
{
"region": "UKD"
},
{
"region": "UKC"
},
{
"region": "UK"
},
{
"region": "UK"
},
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKH"
},
{
"region": "UKG"
},
{
"region": "UKF"
},
{
"region": "UKH"
},
{
"region": "UKG"
},
{
"region": "UKF"
}
],
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKK"
},
{
"region": "UKJ"
},
{
"region": "UKI"
},
{
"region": "UKK"
},
{
"region": "UKJ"
},
{
"region": "UKI"
}
],
"relatedLot": "3"
}
],
"communication": {
"futureNoticeDate": "2023-01-12T00:00:00Z"
},
"coveredBy": [
"GPA"
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "Following the PIN notice and market engagement exercise, it was apparent that competition was absent and direct awards have been placed with all capable providers for each of the Lots. The PIN and market engagement documentation clearly stated that commissioners would consider placing direct awards where competition is deemed to be absent following a review of the market engagement responses."
},
"parties": [
{
"id": "GB-FTS-4052",
"name": "NHS England - Specialised Commissioning",
"identifier": {
"legalName": "NHS England - Specialised Commissioning",
"id": "na"
},
"address": {
"streetAddress": "80 London Road",
"locality": "London",
"region": "UK",
"postalCode": "SE1 6LH",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Josselin Canevet",
"telephone": "+44 1234567890",
"email": "josselin.canevet@nhs.net",
"url": "https://uk.eu-supply.com/ctm/Supplier/Documents/Folder/52947"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.england.nhs.uk",
"buyerProfile": "https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/68205",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-18796",
"name": "Manchester University NHS Foundation Trust",
"identifier": {
"legalName": "Manchester University NHS Foundation Trust"
},
"address": {
"locality": "Manchester",
"region": "UKD",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-1009",
"name": "Birmingham Women's and Children's NHS Foundation Trust",
"identifier": {
"legalName": "Birmingham Women's and Children's NHS Foundation Trust"
},
"address": {
"locality": "Birmingham",
"region": "UKG",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-95413",
"name": "Great Ormond Street Hospital for Children NHS Foundation Trust",
"identifier": {
"legalName": "Great Ormond Street Hospital for Children NHS Foundation Trust"
},
"address": {
"locality": "London",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-6625",
"name": "Cambridge University Hospitals NHS Foundation Trust",
"identifier": {
"legalName": "Cambridge University Hospitals NHS Foundation Trust"
},
"address": {
"locality": "Cambridge",
"region": "UKH",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust",
"identifier": {
"legalName": "Guy's and St Thomas' NHS Foundation Trust"
},
"address": {
"locality": "London",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-122",
"name": "Oxford University Hospitals NHS Foundation Trust",
"identifier": {
"legalName": "Oxford University Hospitals NHS Foundation Trust"
},
"address": {
"locality": "Oxford",
"region": "UKI",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-2639",
"name": "Arden & GEM Commissioning Support Unit",
"identifier": {
"legalName": "Arden & GEM Commissioning Support Unit"
},
"address": {
"locality": "Derby",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody",
"mediationBody",
"reviewContactPoint"
]
},
{
"id": "GB-FTS-130973",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Wellington House, 133-135 Waterloo Rd",
"locality": "London",
"region": "UKI",
"postalCode": "SE1 8UG",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Anna Salt",
"email": "anna.salt@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/"
}
},
{
"id": "GB-FTS-148352",
"name": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST",
"identifier": {
"legalName": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST",
"id": "00000N/A"
},
"address": {
"streetAddress": "Hills Road",
"locality": "Cambridge",
"region": "UKH",
"postalCode": "CB2 0QQ",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "cuh.procurement@nhs.net"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-141301",
"name": "NHS Arden and Greater East Midlands Commissioning Support Unit",
"identifier": {
"legalName": "NHS Arden and Greater East Midlands Commissioning Support Unit"
},
"address": {
"streetAddress": "Cardinal Square, 10 Nottingham Road",
"locality": "Derby",
"postalCode": "DE1 3QT",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.ardengemcsu.nhs.uk/"
}
}
],
"buyer": {
"id": "GB-FTS-130973",
"name": "NHS England"
},
"language": "en",
"awards": [
{
"id": "030459-2023-1-1",
"relatedLots": [
"1"
],
"title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-18796",
"name": "Manchester University NHS Foundation Trust"
}
]
},
{
"id": "030459-2023-2-2",
"relatedLots": [
"2"
],
"title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-1009",
"name": "Birmingham Women's and Children's NHS Foundation Trust"
},
{
"id": "GB-FTS-6625",
"name": "Cambridge University Hospitals NHS Foundation Trust"
}
]
},
{
"id": "030459-2023-3-3",
"relatedLots": [
"3"
],
"title": "Lot 3 - London and the South: comprising the South East; the South West; London",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-95413",
"name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
},
{
"id": "GB-FTS-21063",
"name": "Guy's and St Thomas' NHS Foundation Trust"
},
{
"id": "GB-FTS-122",
"name": "Oxford University Hospitals NHS Foundation Trust"
}
]
},
{
"id": "044469-2026-1-1",
"relatedLots": [
"1"
],
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148352",
"name": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
}
]
},
{
"id": "044470-2026-1-1",
"relatedLots": [
"1"
],
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148352",
"name": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
}
]
},
{
"id": "045612-2026-1-1",
"relatedLots": [
"1"
],
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148352",
"name": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
}
]
},
{
"id": "045613-2026-1-1",
"relatedLots": [
"1"
],
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-148352",
"name": "CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST"
}
]
}
],
"contracts": [
{
"id": "030459-2023-1-1",
"awardID": "030459-2023-1-1",
"title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
"status": "active",
"value": {
"amount": 2797834,
"currency": "GBP"
},
"dateSigned": "2023-03-10T00:00:00Z"
},
{
"id": "030459-2023-2-2",
"awardID": "030459-2023-2-2",
"title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
"status": "active",
"value": {
"amount": 1480332,
"currency": "GBP"
},
"dateSigned": "2023-03-10T00:00:00Z"
},
{
"id": "030459-2023-3-3",
"awardID": "030459-2023-3-3",
"title": "Lot 3 - London and the South: comprising the South East; the South West; London",
"status": "active",
"value": {
"amount": 5574979,
"currency": "GBP"
},
"dateSigned": "2023-03-10T00:00:00Z"
},
{
"id": "044469-2026-1-1",
"awardID": "044469-2026-1-1",
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"value": {
"amount": 12139810,
"currency": "GBP"
},
"dateSigned": "2026-04-01T00:00:00+01:00",
"period": {
"startDate": "2026-04-01T00:00:00+01:00",
"endDate": "2026-11-30T23:59:59Z"
},
"items": [
{
"id": "1",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"amendments": [
{
"id": "1",
"description": "The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023(PSR).<br/>The modification will extend the existing contract for an additional 8 months and the value of the modification is PS2,286,667. The initial contract award value was PS9,853,146.<br/>The modification effective date is 1st April 2026.",
"rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023 (PSR)."
}
]
},
{
"id": "044470-2026-1-1",
"awardID": "044470-2026-1-1",
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"value": {
"amount": 12139810,
"currency": "GBP"
},
"dateSigned": "2026-04-01T00:00:00+01:00",
"period": {
"startDate": "2026-04-01T00:00:00+01:00",
"endDate": "2026-11-30T23:59:59Z"
},
"items": [
{
"id": "1",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"amendments": [
{
"id": "2",
"description": "The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023(PSR).<br/>The modification will extend the existing contract for an additional 8 months and the value of the modification is PS2,286,667. The initial contract award value was PS9,853,146.<br/>The modification effective date is 1st April 2026.",
"rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023 (PSR)."
}
]
},
{
"id": "045612-2026-1-1",
"awardID": "045612-2026-1-1",
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"value": {
"amount": 12139810,
"currency": "GBP"
},
"dateSigned": "2026-04-01T00:00:00+01:00",
"period": {
"startDate": "2026-04-01T00:00:00+01:00",
"endDate": "2026-11-30T23:59:59Z"
},
"items": [
{
"id": "1",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"amendments": [
{
"id": "3",
"description": "The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023(PSR).<br/>The modification will extend the existing contract for an additional 8 months and the value of the modification is PS2,286,667. The initial contract award value was PS9,853,146.<br/>The modification effective date is 1st April 2026.",
"rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023 (PSR)."
}
]
},
{
"id": "045613-2026-1-1",
"awardID": "045613-2026-1-1",
"title": "Multiple Sclerosis Management Service for Children - Contract Modification",
"status": "active",
"value": {
"amount": 12139810,
"currency": "GBP"
},
"dateSigned": "2026-04-01T00:00:00+01:00",
"period": {
"startDate": "2026-04-01T00:00:00+01:00",
"endDate": "2026-11-30T23:59:59Z"
},
"items": [
{
"id": "1",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"amendments": [
{
"id": "4",
"description": "The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023(PSR).<br/>The modification will extend the existing contract for an additional 8 months and the value of the modification is PS2,286,667. The initial contract award value was PS9,853,146.<br/>The modification effective date is 1st April 2026.",
"rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: The contract modification is required to allow the service to continue while allowing sufficient time to identify and complete the most appropriate procurement route in accordance with The Healthcare Services (Provider Selection Regime) Regulations 2023 (PSR)."
}
]
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "2",
"measure": "bids",
"relatedLot": "2",
"value": 2
},
{
"id": "3",
"measure": "bids",
"relatedLot": "3",
"value": 4
}
]
}
}